M. Jachym

Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort.

E. Caumes, N. Veziris, N. Metivier, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Isoniazid-monoresistant tuberculosis in France: risk factors, treatment outcomes and adverse events.

Y. Yazdanpanah, C. Londner, B. Fantin, 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

A. Spanevello, D. Visca, G. Sotgiu, 2020, European Respiratory Journal.

Multidrug-resistant tuberculous meningitis in an HIV-positive patient: a challenging disease.

P. Yeni, R. Ruimy, A. Meybeck, 2007, AIDS patient care and STDs.

Barriers and facilitators to early access of bedaquiline and delamanid for MDR-TB: a mixed-methods study.

C. Mitnick, M. Brooks, F. Varaine, 2019, Public health action.

Visualizing viable Mycobacterium tuberculosis in sputum to monitor isolation measures.

B. Wyplosz, E. Cambau, F. Mougari, 2017, The Journal of infection.

Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort.

E. Caumes, N. Veziris, N. Metivier, 2015, Clinical Infectious Diseases.